Home › Companies › Ginkgo Bioworks Holdings, Inc. › 2025-2026

Ginkgo Bioworks Holdings, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Ginkgo Bioworks Holdings, Inc.’s Form 8-K, filed 2026-06-12 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 7Reported items
  • 207Asset managers
  • 1,063Fund votes
  • 2026-06-11Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Ginkgo Bioworks Holdings, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Ginkgo Bioworks Holdings, Inc.

These tallies are Ginkgo Bioworks Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Ginkgo Bioworks Holdings, Inc. — official shareholder meeting results, meeting held 2026-06-11
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Jason Kelly 84,007,04048,2100 ---- Majority: yes
Elect Director: Reshma Shetty 84,007,04048,2100 ---- Majority: yes
Elect Director: Ross Fubini 100,125,5717,977,1433,696,487 --11,792,897 Majority: yes
Elect Director: Christian Henry 94,211,34513,927,0763,660,780 --11,792,897 Majority: yes
Elect Director: Sri Kosuri 99,675,9078,421,3563,701,938 --11,792,897 Majority: yes
Elect Director: Harry E. Sloan 97,315,31710,788,3123,695,572 --11,792,897 Majority: yes
Pursuant to the foregoing votes, the six nominees listed above were elected to serve on the Company's Board of Directors. There were no additional director nominations brought before the meeting. 119,527,721267,7273,796,650 --0 Majority: yes
Pursuant to the foregoing vote, the ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved. 3. 95,058,58512,502,1534,238,463 --11,792,897 Passed

Source: Ginkgo Bioworks Holdings, Inc., Form 8-K, filed with the SEC on 2026-06-12 — read the filing on EDGAR.

How asset managers voted at the Ginkgo Bioworks Holdings, Inc. 2025-2026 meeting

Each item below shows how the 207 asset managers that disclosed a Ginkgo Bioworks Holdings, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Ginkgo Bioworks Holdings, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote to approve executive compensation.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

43% fund support · no official result

FOR 34%AGAINST 46.0%ABSTAIN 20%

The 202 asset managers below cast 43% of the shares they voted on this item FOR (7,077,187 for, 9,549,071 against).

FOR: 7,077,187 (34.1%)AGAINST: 9,549,071 (46.0%)ABSTAIN: 4,118,984 (19.9%)
Largest asset managers voting on “Advisory vote to approve executive compensation.” at Ginkgo Bioworks Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
VIKING GLOBAL INVESTORS LP00 3,577,1280Abstain
Vanguard624,0301,684,730 110Against
BAILLIE GIFFORD & CO LTD2,141,6490 00For
BlackRock107,7281,866,518 00Against
Capital Group1,746,3630 00For
Legal & General Investment Management Ltd01,187,141 00Against
FORBES J M & CO LLP1,028,3910 00For
GEODE CAPITAL MANAGEMENT, LLC0772,649 00Against
State Street661,5639,541 00For
Charles Schwab0665,677 00Against
Fidelity0635,807 00Against
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.00 541,8450Abstain
PIMCO0489,372 00Against
EXCHANGE TRADED CONCEPTS TRUST0321,721 00Against
Northern Trust0287,458 00Against
PACIFIC INVESTMENT MANAGEMENT CO LLC0215,444 00Against
American Century0174,772 00Against
Universal-Investment-Gesellschaft mbH140,0000 00For
T. Rowe Price0125,618 00Against
JACOBS LEVY EQUITY MANAGEMENT, INC0116,102 00Against
a16z Capital Management, L.L.C.108,1120 00For
Ensign Peak Advisors, Inc104,8280 00For
MELLON INVESTMENTS Corp086,693 00Against
Northern Lights Fund Trust IV83,2680 00For
REGENTS OF THE UNIVERSITY OF CALIFORNIA069,160 00Against

Showing the 25 largest of 202 asset managers. See all 202 in the interactive database.

2. Election of Directors: Christian Henry

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%13%
FOR: 94,211,345AGAINST: 13,927,076

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Christian Henry”): 94,211,345 for, 13,927,076 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 49 asset managers below cast 14% of the shares they voted on this item FOR (815,064 for, 4,979,358 against).

FOR 14%AGAINST 86%
FOR: 815,064 (14.1%)AGAINST: 4,979,358 (85.9%)ABSTAIN: 9 (0.0%)
Largest asset managers voting on “Election of Directors: Christian Henry” at Ginkgo Bioworks Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard2,7681,991,068 90Against
BlackRock01,213,171 00Against
Fidelity618,00716,667 00For
PIMCO0489,372 00Against
Charles Schwab0332,833 00Against
EXCHANGE TRADED CONCEPTS TRUST0321,721 00Against
State Street196171,431 00Against
American Century087,386 00Against
Northern Lights Fund Trust IV83,2680 00For
MFS040,639 00Against
Columbia Threadneedle40,3830 00For
QUANTITATIVE MASTER SERIES LLC037,656 00Against
Equitable031,363 00Against
Nationwide028,969 00Against
Lincoln Financial028,400 00Against
AIG/SunAmerica022,017 00Against
Jackson National19,8100 00For
Global X019,679 00Against
Bridge Builder Trust018,688 00Against
Northern Trust16,4450 00For
TIAA16,0490 00For
T. Rowe Price015,919 00Against
Pacific Life015,766 00Against
Brighthouse011,484 00Against
John Hancock011,342 00Against

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

3. Election of Directors: Harry E. Sloan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 97,315,317AGAINST: 10,788,312

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Harry E. Sloan”): 97,315,317 for, 10,788,312 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 49 asset managers below cast 59% of the shares they voted on this item FOR (3,426,086 for, 2,368,335 against).

FOR 59%AGAINST 41%
FOR: 3,426,086 (59.1%)AGAINST: 2,368,335 (40.9%)ABSTAIN: 9 (0.0%)
Largest asset managers voting on “Election of Directors: Harry E. Sloan” at Ginkgo Bioworks Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,989,0864,750 90For
BlackRock1,213,1710 00For
Fidelity16,667618,007 00Against
PIMCO0489,372 00Against
Charles Schwab0332,833 00Against
EXCHANGE TRADED CONCEPTS TRUST0321,721 00Against
State Street196171,431 00Against
American Century087,386 00Against
Northern Lights Fund Trust IV83,2680 00For
MFS040,639 00Against
Columbia Threadneedle040,383 00Against
QUANTITATIVE MASTER SERIES LLC37,6560 00For
Equitable20,83310,530 00For
Nationwide2,17326,796 00Against
Lincoln Financial028,400 00Against
AIG/SunAmerica022,017 00Against
Jackson National019,810 00Against
Global X019,679 00Against
Bridge Builder Trust18,6880 00For
Northern Trust016,445 00Against
TIAA016,049 00Against
T. Rowe Price15,9190 00For
Pacific Life15,7660 00For
Brighthouse011,484 00Against
John Hancock011,342 00Against

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

4. Election of Directors: Ross Fubini

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%
FOR: 100,125,571AGAINST: 7,977,143

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Ross Fubini”): 100,125,571 for, 7,977,143 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 49 asset managers below cast 71% of the shares they voted on this item FOR (4,107,225 for, 1,687,196 against).

FOR 71%AGAINST 29%
FOR: 4,107,225 (70.9%)AGAINST: 1,687,196 (29.1%)ABSTAIN: 9 (0.0%)
Largest asset managers voting on “Election of Directors: Ross Fubini” at Ginkgo Bioworks Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,993,81224 90For
BlackRock1,213,1710 00For
Fidelity16,667618,007 00Against
PIMCO0489,372 00Against
Charles Schwab332,8330 00For
EXCHANGE TRADED CONCEPTS TRUST0321,721 00Against
State Street171,465162 00For
American Century087,386 00Against
Northern Lights Fund Trust IV83,2680 00For
MFS40,6390 00For
Columbia Threadneedle40,3830 00For
QUANTITATIVE MASTER SERIES LLC37,6560 00For
Equitable20,83310,530 00For
Nationwide2,17326,796 00Against
Lincoln Financial28,4000 00For
AIG/SunAmerica022,017 00Against
Jackson National19,8100 00For
Global X19,6790 00For
Bridge Builder Trust18,6880 00For
Northern Trust16,4450 00For
TIAA016,049 00Against
T. Rowe Price015,919 00Against
Pacific Life15,7660 00For
Brighthouse011,484 00Against
John Hancock011,342 00Against

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

5. Election of Directors: Sri Kosuri

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 99,675,907AGAINST: 8,421,356

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Sri Kosuri”): 99,675,907 for, 8,421,356 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 49 asset managers below cast 80% of the shares they voted on this item FOR (4,655,048 for, 1,139,374 against).

FOR 80%AGAINST 20%
FOR: 4,655,048 (80.3%)AGAINST: 1,139,374 (19.7%)ABSTAIN: 9 (0.0%)
Largest asset managers voting on “Election of Directors: Sri Kosuri” at Ginkgo Bioworks Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,992,2701,567 90For
BlackRock1,213,1710 00For
Fidelity634,6740 00For
PIMCO0489,372 00Against
Charles Schwab332,8330 00For
EXCHANGE TRADED CONCEPTS TRUST0321,721 00Against
State Street171,465162 00For
American Century087,386 00Against
Northern Lights Fund Trust IV83,2680 00For
MFS040,639 00Against
Columbia Threadneedle40,3830 00For
QUANTITATIVE MASTER SERIES LLC37,6560 00For
Equitable20,83310,530 00For
Nationwide2,17326,796 00Against
Lincoln Financial28,4000 00For
AIG/SunAmerica022,017 00Against
Jackson National019,810 00Against
Global X019,679 00Against
Bridge Builder Trust18,6880 00For
Northern Trust16,4450 00For
TIAA16,0490 00For
T. Rowe Price15,9190 00For
Pacific Life15,7660 00For
Brighthouse011,484 00Against
John Hancock011,342 00Against

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

6. Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

AUDIT-RELATEDCompany result: Passed

Combines 2 wordings of this item as funds reported it.

88% Passed · of votes cast

FOR 88%12%
FOR: 95,058,585AGAINST: 12,502,153

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Pursuant to the foregoing vote, the ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved. 3.”): 95,058,585 for, 12,502,153 against — passed, per its Form 8-K filed 2026-06-12 (Item 5.07). Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 49 asset managers below cast 99.9% of the shares they voted on this item FOR (5,790,821 for, 3,601 against).

FOR 99.9%
FOR: 5,790,821 (99.9%)AGAINST: 3,601 (0.1%)ABSTAIN: 9 (0.0%)
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm ” at Ginkgo Bioworks Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,990,6603,177 90For
BlackRock1,213,1710 00For
Fidelity634,6740 00For
PIMCO489,3720 00For
Charles Schwab332,8330 00For
EXCHANGE TRADED CONCEPTS TRUST321,7210 00For
State Street171,454173 00For
American Century87,3860 00For
Northern Lights Fund Trust IV83,2680 00For
MFS40,6390 00For
Columbia Threadneedle40,3830 00For
QUANTITATIVE MASTER SERIES LLC37,6560 00For
Equitable31,3630 00For
Nationwide28,9690 00For
Lincoln Financial28,4000 00For
AIG/SunAmerica22,0170 00For
Jackson National19,8100 00For
Global X19,6790 00For
Bridge Builder Trust18,6880 00For
Northern Trust16,4450 00For
TIAA16,0490 00For
T. Rowe Price15,9190 00For
Pacific Life15,7660 00For
Brighthouse11,4840 00For
John Hancock11,3420 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

7. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

99% fund support · no official result

FOR 99%

The 3 asset managers below cast 99% of the shares they voted on this item FOR (610,729 for, 8,430 against).

FOR: 610,729 (98.6%)AGAINST: 8,430 (1.4%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Ginkgo Bioworks Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
SB INVESTMENT ADVISERS (UK) LTD610,7290 00For
CLEARWATER INVESTMENT TRUST08,380 00Against
TD Waterhouse Canada Inc.050 00Against

Largest Ginkgo Bioworks Holdings, Inc. shareholders voting in 2025-2026

Ranked by the number of Ginkgo Bioworks Holdings, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 61,660,788 shares outstanding at the time of that meeting.

Top Ginkgo Bioworks Holdings, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1VIKING GLOBAL INVESTORS LP 5.80%
2Vanguard 3.74%
3BAILLIE GIFFORD & CO LTD 3.47%
4BlackRock 3.20%
5Capital Group 2.83%
6Legal & General Investment Management Ltd 1.93%
7FORBES J M & CO LLP 1.67%
8GEODE CAPITAL MANAGEMENT, LLC 1.25%
9State Street 1.09%
10Charles Schwab 1.08%

Reported Ginkgo Bioworks Holdings, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Ginkgo Bioworks Holdings, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 5.91% 13F
Cascade Investment, L.L.C. 5.87% DEF14A
VIKING GLOBAL INVESTORS LP 5.80% 13G
Vanguard Group 4.70% 13F
BAILLIE GIFFORD & CO 3.88% 13G
State Street 2.18% 13F
Geode Capital 1.64% 13F
Goldman Sachs 1.51% 13F
Bartholomew Canton 1.26% DEF14A
Reshma Shetty 1.26% DEF14A

Percentages above are of 61,660,788 shares outstanding, as reported by Ginkgo Bioworks Holdings, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Ginkgo Bioworks Holdings, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Ginkgo Bioworks Holdings, Inc.'s shareholder meeting held 2026-06-11, in the 2025-2026 proxy season, 207 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,063 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Ginkgo Bioworks Holdings, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Advisory vote to approve executive compensation. — the reporting funds cast 43% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Ginkgo Bioworks Holdings, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).